Therapeutic agent for tissue damage

Provided is a therapeutic agent for tissue damage. A therapeutic agent for tissue damage, the therapeutic agent containing at least one selected from the group consisting of IL-1R1 function inhibitors, IL-1R1 expression inhibitors, MyD88 function inhibitors, and MyD88 expression inhibitors.